AACR Stories
A grant supported by individual donors to the AACR is helping Madelyn Espinosa-Cotton, PhD, pursue promising new research on a rare form of sarcoma that strikes teens and young adults.
Learn More in AACR Stories
A grant supported by individual donors to the AACR is helping Madelyn Espinosa-Cotton, PhD, pursue promising new research on a rare form of sarcoma that strikes teens and young adults.
Learn More in AACR Stories
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreDisparities in Cancer Screening: Racial and ethnic minority populations and medically underserved communities experience substantial disparities in receiving the recommended cancer screenings.
Read the ReportChildhood acute lymphoblastic leukemia (ALL) is the most common type of pediatric cancer. September is Childhood Cancer Awareness Month.
Learn MoreResearchers are shedding light on the multifaceted ways that extrachromosomal DNA impacts cancer development and resistance to targeted therapies.
Learn MoreRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe Call for Abstracts for the AACR Annual Meeting 2027 (April 2-7) is now available. Abstract submission will open in late September.
Abstract Deadline: November 10
The AACR Cancer Disparities Progress Report 2026 provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn MoreThe AACR and its more than 65,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 65,000 members worldwide drive progress against cancer.
Donate Now
